Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nivalon Medical Technologies is an Israeli medical device company focused on developing innovative cryo-ablation solutions for the treatment of cardiac arrhythmias, specifically atrial fibrillation. As a portfolio company of the Rainbow Medical incubator, Nivalon leverages a proprietary cooling technology designed to achieve precise and effective pulmonary vein isolation. The company's system aims to overcome the limitations of traditional radiofrequency and existing cryo-balloon ablation methods by providing more controlled lesion formation and improved safety profiles. By utilizing a minimally invasive catheter-based approach, Nivalon seeks to enhance procedural efficiency and long-term patient outcomes in the field of electrophysiology. The company is currently advancing its technology through clinical feasibility studies to validate its performance in treating complex cardiac conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nivalon Medical Technologies.